Cucurbitacin e induces cell cycle G2/M phase arrest and apoptosis in triple negative breast cancer

72Citations
Citations of this article
64Readers
Mendeley users who have this article in their library.

Abstract

Triple negative breast cancer (TNBC) is a highly aggressive form of breast cancer resistant to many common treatments. In this study, we compared the effects of 12 phytochemical drugs on four cancer cell lines, and noticed that Cucurbitacin E (CuE) significantly inhibited TNBC cell growth by inducing cell cycle G2/M phase arrest and apoptosis. CuE reduced expression of Cyclin D1, Survivin, XIAP, Bcl2, and Mcl-1 in MDA-MB-468 and SW527, and within MDA-MB-468, CuE significantly increased activation of JNK and inhibited activation of AKT and ERK. Collectively, these results suggest that CuE may be a viable compound for developing novel TNBC therapeutics. © 2014 Kong et al.

Cite

CITATION STYLE

APA

Kong, Y., Chen, J., Zhou, Z., Xia, H., Qiu, M. H., & Chen, C. (2014). Cucurbitacin e induces cell cycle G2/M phase arrest and apoptosis in triple negative breast cancer. PLoS ONE, 9(7). https://doi.org/10.1371/journal.pone.0103760

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free